Part 1
Part 2
Part 3
Part 5
Market Analysis and Insights: Global and United States Rapid Antigen Testing (RAT) for COVID-19 Market This report focuses on global and United States Rapid Antigen Testing (RAT) for COVID-19 market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Rapid Antigen Testing (RAT) for COVID-19 market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Fluorescence Immunochromatography accounting for % of the Rapid Antigen Testing (RAT) for COVID-19 global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospitals was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period. In United States the Rapid Antigen Testing (RAT) for COVID-19 market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028. Global Rapid Antigen Testing (RAT) for COVID-19 Scope and Market Size Rapid Antigen Testing (RAT) for COVID-19 market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Rapid Antigen Testing (RAT) for COVID-19 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Rapid Antigen Testing (RAT) for COVID-19 market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States. Segment by Type Fluorescence Immunochromatography Colloidal Gold Immunochromatography Latex Immunochromatography Others Segment by Application Hospitals Community Testing Other By Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Colombia Middle East & Africa Turkey Saudi Arabia UAE By Company Abbott Quidel ACCESS BIO CTK Biotech SD Biosensor Ellume InBios Celltrion AESKU.GROUP ROCHE BD OraSure Technologies Clip Health LumiraDx Princeton BioMeditech Corporation RapiGEN Inc. Orient Gene Wondfo Biotech Ihealth (Andon Health) Wantai BioPharm Biotest Biotech Shenzhen YHLO Biotech Vazyme Biotech EasyDiagnosis Biomedicine Beijing Hotgen Biotech Assure Tech Hangzhou AllTest Biotech ACON Biotech BGI Genomics Lepu Medical Technology
1 Study Coverage
1.1 Rapid Antigen Testing (RAT) for COVID-19 Product Introduction
1.2 Global Rapid Antigen Testing (RAT) for COVID-19 Outlook 2017 VS 2022 VS 2028
1.2.1 Global Rapid Antigen Testing (RAT) for COVID-19 Sales in US$ Million for the Year 2017-2028
1.2.2 Global Rapid Antigen Testing (RAT) for COVID-19 Sales in Volume for the Year 2017-2028
1.3 United States Rapid Antigen Testing (RAT) for COVID-19 Outlook 2017 VS 2022 VS 2028
1.3.1 United States Rapid Antigen Testing (RAT) for COVID-19 Sales in US$ Million for the Year 2017-2028
1.3.2 United States Rapid Antigen Testing (RAT) for COVID-19 Sales in Volume for the Year 2017-2028
1.4 Rapid Antigen Testing (RAT) for COVID-19 Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Rapid Antigen Testing (RAT) for COVID-19 in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Rapid Antigen Testing (RAT) for COVID-19 Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Rapid Antigen Testing (RAT) for COVID-19 Market Dynamics
1.5.1 Rapid Antigen Testing (RAT) for COVID-19 Industry Trends
1.5.2 Rapid Antigen Testing (RAT) for COVID-19 Market Drivers
1.5.3 Rapid Antigen Testing (RAT) for COVID-19 Market Challenges
1.5.4 Rapid Antigen Testing (RAT) for COVID-19 Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Rapid Antigen Testing (RAT) for COVID-19 Market Segment by Type
2.1.1 Fluorescence Immunochromatography
2.1.2 Colloidal Gold Immunochromatography
2.1.3 Latex Immunochromatography
2.1.4 Others
2.2 Global Rapid Antigen Testing (RAT) for COVID-19 Market Size by Type
2.2.1 Global Rapid Antigen Testing (RAT) for COVID-19 Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Rapid Antigen Testing (RAT) for COVID-19 Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Rapid Antigen Testing (RAT) for COVID-19 Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Rapid Antigen Testing (RAT) for COVID-19 Market Size by Type
2.3.1 United States Rapid Antigen Testing (RAT) for COVID-19 Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Rapid Antigen Testing (RAT) for COVID-19 Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Rapid Antigen Testing (RAT) for COVID-19 Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Rapid Antigen Testing (RAT) for COVID-19 Market Segment by Application
3.1.1 Hospitals
3.1.2 Community Testing
3.1.3 Other
3.2 Global Rapid Antigen Testing (RAT) for COVID-19 Market Size by Application
3.2.1 Global Rapid Antigen Testing (RAT) for COVID-19 Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Rapid Antigen Testing (RAT) for COVID-19 Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Rapid Antigen Testing (RAT) for COVID-19 Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Rapid Antigen Testing (RAT) for COVID-19 Market Size by Application
3.3.1 United States Rapid Antigen Testing (RAT) for COVID-19 Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Rapid Antigen Testing (RAT) for COVID-19 Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Rapid Antigen Testing (RAT) for COVID-19 Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Rapid Antigen Testing (RAT) for COVID-19 Competitor Landscape by Company
4.1 Global Rapid Antigen Testing (RAT) for COVID-19 Market Size by Company
4.1.1 Top Global Rapid Antigen Testing (RAT) for COVID-19 Manufacturers Ranked by Revenue (2021)
4.1.2 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Manufacturer (2017-2022)
4.1.3 Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Manufacturer (2017-2022)
4.1.4 Global Rapid Antigen Testing (RAT) for COVID-19 Price by Manufacturer (2017-2022)
4.2 Global Rapid Antigen Testing (RAT) for COVID-19 Concentration Ratio (CR)
4.2.1 Rapid Antigen Testing (RAT) for COVID-19 Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Rapid Antigen Testing (RAT) for COVID-19 in 2021
4.2.3 Global Rapid Antigen Testing (RAT) for COVID-19 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Rapid Antigen Testing (RAT) for COVID-19 Manufacturing Base Distribution, Product Type
4.3.1 Global Rapid Antigen Testing (RAT) for COVID-19 Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Rapid Antigen Testing (RAT) for COVID-19 Product Type
4.3.3 Date of International Manufacturers Enter into Rapid Antigen Testing (RAT) for COVID-19 Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Rapid Antigen Testing (RAT) for COVID-19 Market Size by Company
4.5.1 Top Rapid Antigen Testing (RAT) for COVID-19 Players in United States, Ranked by Revenue (2021)
4.5.2 United States Rapid Antigen Testing (RAT) for COVID-19 Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Rapid Antigen Testing (RAT) for COVID-19 Sales by Players (2020, 2021 & 2022)
5 Global Rapid Antigen Testing (RAT) for COVID-19 Market Size by Region
5.1 Global Rapid Antigen Testing (RAT) for COVID-19 Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Rapid Antigen Testing (RAT) for COVID-19 Market Size in Volume by Region (2017-2028)
5.2.1 Global Rapid Antigen Testing (RAT) for COVID-19 Sales in Volume by Region: 2017-2022
5.2.2 Global Rapid Antigen Testing (RAT) for COVID-19 Sales in Volume Forecast by Region (2023-2028)
5.3 Global Rapid Antigen Testing (RAT) for COVID-19 Market Size in Value by Region (2017-2028)
5.3.1 Global Rapid Antigen Testing (RAT) for COVID-19 Sales in Value by Region: 2017-2022
5.3.2 Global Rapid Antigen Testing (RAT) for COVID-19 Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Rapid Antigen Testing (RAT) for COVID-19 Market Size YoY Growth 2017-2028
6.1.2 North America Rapid Antigen Testing (RAT) for COVID-19 Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Rapid Antigen Testing (RAT) for COVID-19 Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Rapid Antigen Testing (RAT) for COVID-19 Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Rapid Antigen Testing (RAT) for COVID-19 Market Size YoY Growth 2017-2028
6.3.2 Europe Rapid Antigen Testing (RAT) for COVID-19 Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Rapid Antigen Testing (RAT) for COVID-19 Market Size YoY Growth 2017-2028
6.4.2 Latin America Rapid Antigen Testing (RAT) for COVID-19 Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.4.6 Colombia
6.5 Middle East and Africa
6.5.1 Middle East and Africa Rapid Antigen Testing (RAT) for COVID-19 Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Rapid Antigen Testing (RAT) for COVID-19 Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Corporation Information
7.1.2 Abbott Description and Business Overview
7.1.3 Abbott Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Abbott Rapid Antigen Testing (RAT) for COVID-19 Products Offered
7.1.5 Abbott Recent Development
7.2 Quidel
7.2.1 Quidel Corporation Information
7.2.2 Quidel Description and Business Overview
7.2.3 Quidel Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Quidel Rapid Antigen Testing (RAT) for COVID-19 Products Offered
7.2.5 Quidel Recent Development
7.3 ACCESS BIO
7.3.1 ACCESS BIO Corporation Information
7.3.2 ACCESS BIO Description and Business Overview
7.3.3 ACCESS BIO Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
7.3.4 ACCESS BIO Rapid Antigen Testing (RAT) for COVID-19 Products Offered
7.3.5 ACCESS BIO Recent Development
7.4 CTK Biotech
7.4.1 CTK Biotech Corporation Information
7.4.2 CTK Biotech Description and Business Overview
7.4.3 CTK Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
7.4.4 CTK Biotech Rapid Antigen Testing (RAT) for COVID-19 Products Offered
7.4.5 CTK Biotech Recent Development
7.5 SD Biosensor
7.5.1 SD Biosensor Corporation Information
7.5.2 SD Biosensor Description and Business Overview
7.5.3 SD Biosensor Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
7.5.4 SD Biosensor Rapid Antigen Testing (RAT) for COVID-19 Products Offered
7.5.5 SD Biosensor Recent Development
7.6 Ellume
7.6.1 Ellume Corporation Information
7.6.2 Ellume Description and Business Overview
7.6.3 Ellume Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Ellume Rapid Antigen Testing (RAT) for COVID-19 Products Offered
7.6.5 Ellume Recent Development
7.7 InBios
7.7.1 InBios Corporation Information
7.7.2 InBios Description and Business Overview
7.7.3 InBios Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
7.7.4 InBios Rapid Antigen Testing (RAT) for COVID-19 Products Offered
7.7.5 InBios Recent Development
7.8 Celltrion
7.8.1 Celltrion Corporation Information
7.8.2 Celltrion Description and Business Overview
7.8.3 Celltrion Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Celltrion Rapid Antigen Testing (RAT) for COVID-19 Products Offered
7.8.5 Celltrion Recent Development
7.9 AESKU.GROUP
7.9.1 AESKU.GROUP Corporation Information
7.9.2 AESKU.GROUP Description and Business Overview
7.9.3 AESKU.GROUP Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
7.9.4 AESKU.GROUP Rapid Antigen Testing (RAT) for COVID-19 Products Offered
7.9.5 AESKU.GROUP Recent Development
7.10 ROCHE
7.10.1 ROCHE Corporation Information
7.10.2 ROCHE Description and Business Overview
7.10.3 ROCHE Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
7.10.4 ROCHE Rapid Antigen Testing (RAT) for COVID-19 Products Offered
7.10.5 ROCHE Recent Development
7.11 BD
7.11.1 BD Corporation Information
7.11.2 BD Description and Business Overview
7.11.3 BD Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
7.11.4 BD Rapid Antigen Testing (RAT) for COVID-19 Products Offered
7.11.5 BD Recent Development
7.12 OraSure Technologies
7.12.1 OraSure Technologies Corporation Information
7.12.2 OraSure Technologies Description and Business Overview
7.12.3 OraSure Technologies Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
7.12.4 OraSure Technologies Products Offered
7.12.5 OraSure Technologies Recent Development
7.13 Clip Health
7.13.1 Clip Health Corporation Information
7.13.2 Clip Health Description and Business Overview
7.13.3 Clip Health Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Clip Health Products Offered
7.13.5 Clip Health Recent Development
7.14 LumiraDx
7.14.1 LumiraDx Corporation Information
7.14.2 LumiraDx Description and Business Overview
7.14.3 LumiraDx Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
7.14.4 LumiraDx Products Offered
7.14.5 LumiraDx Recent Development
7.15 Princeton BioMeditech Corporation
7.15.1 Princeton BioMeditech Corporation Corporation Information
7.15.2 Princeton BioMeditech Corporation Description and Business Overview
7.15.3 Princeton BioMeditech Corporation Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Princeton BioMeditech Corporation Products Offered
7.15.5 Princeton BioMeditech Corporation Recent Development
7.16 RapiGEN Inc.
7.16.1 RapiGEN Inc. Corporation Information
7.16.2 RapiGEN Inc. Description and Business Overview
7.16.3 RapiGEN Inc. Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
7.16.4 RapiGEN Inc. Products Offered
7.16.5 RapiGEN Inc. Recent Development
7.17 Orient Gene
7.17.1 Orient Gene Corporation Information
7.17.2 Orient Gene Description and Business Overview
7.17.3 Orient Gene Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Orient Gene Products Offered
7.17.5 Orient Gene Recent Development
7.18 Wondfo Biotech
7.18.1 Wondfo Biotech Corporation Information
7.18.2 Wondfo Biotech Description and Business Overview
7.18.3 Wondfo Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
7.18.4 Wondfo Biotech Products Offered
7.18.5 Wondfo Biotech Recent Development
7.19 Ihealth (Andon Health)
7.19.1 Ihealth (Andon Health) Corporation Information
7.19.2 Ihealth (Andon Health) Description and Business Overview
7.19.3 Ihealth (Andon Health) Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
7.19.4 Ihealth (Andon Health) Products Offered
7.19.5 Ihealth (Andon Health) Recent Development
7.20 Wantai BioPharm
7.20.1 Wantai BioPharm Corporation Information
7.20.2 Wantai BioPharm Description and Business Overview
7.20.3 Wantai BioPharm Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
7.20.4 Wantai BioPharm Products Offered
7.20.5 Wantai BioPharm Recent Development
7.21 Biotest Biotech
7.21.1 Biotest Biotech Corporation Information
7.21.2 Biotest Biotech Description and Business Overview
7.21.3 Biotest Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
7.21.4 Biotest Biotech Products Offered
7.21.5 Biotest Biotech Recent Development
7.22 Shenzhen YHLO Biotech
7.22.1 Shenzhen YHLO Biotech Corporation Information
7.22.2 Shenzhen YHLO Biotech Description and Business Overview
7.22.3 Shenzhen YHLO Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
7.22.4 Shenzhen YHLO Biotech Products Offered
7.22.5 Shenzhen YHLO Biotech Recent Development
7.23 Vazyme Biotech
7.23.1 Vazyme Biotech Corporation Information
7.23.2 Vazyme Biotech Description and Business Overview
7.23.3 Vazyme Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
7.23.4 Vazyme Biotech Products Offered
7.23.5 Vazyme Biotech Recent Development
7.24 EasyDiagnosis Biomedicine
7.24.1 EasyDiagnosis Biomedicine Corporation Information
7.24.2 EasyDiagnosis Biomedicine Description and Business Overview
7.24.3 EasyDiagnosis Biomedicine Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
7.24.4 EasyDiagnosis Biomedicine Products Offered
7.24.5 EasyDiagnosis Biomedicine Recent Development
7.25 Beijing Hotgen Biotech
7.25.1 Beijing Hotgen Biotech Corporation Information
7.25.2 Beijing Hotgen Biotech Description and Business Overview
7.25.3 Beijing Hotgen Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
7.25.4 Beijing Hotgen Biotech Products Offered
7.25.5 Beijing Hotgen Biotech Recent Development
7.26 Assure Tech
7.26.1 Assure Tech Corporation Information
7.26.2 Assure Tech Description and Business Overview
7.26.3 Assure Tech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
7.26.4 Assure Tech Products Offered
7.26.5 Assure Tech Recent Development
7.27 Hangzhou AllTest Biotech
7.27.1 Hangzhou AllTest Biotech Corporation Information
7.27.2 Hangzhou AllTest Biotech Description and Business Overview
7.27.3 Hangzhou AllTest Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
7.27.4 Hangzhou AllTest Biotech Products Offered
7.27.5 Hangzhou AllTest Biotech Recent Development
7.28 ACON Biotech
7.28.1 ACON Biotech Corporation Information
7.28.2 ACON Biotech Description and Business Overview
7.28.3 ACON Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
7.28.4 ACON Biotech Products Offered
7.28.5 ACON Biotech Recent Development
7.29 BGI Genomics
7.29.1 BGI Genomics Corporation Information
7.29.2 BGI Genomics Description and Business Overview
7.29.3 BGI Genomics Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
7.29.4 BGI Genomics Products Offered
7.29.5 BGI Genomics Recent Development
7.30 Lepu Medical Technology
7.30.1 Lepu Medical Technology Corporation Information
7.30.2 Lepu Medical Technology Description and Business Overview
7.30.3 Lepu Medical Technology Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2017-2022)
7.30.4 Lepu Medical Technology Products Offered
7.30.5 Lepu Medical Technology Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Rapid Antigen Testing (RAT) for COVID-19 Industry Chain Analysis
8.2 Rapid Antigen Testing (RAT) for COVID-19 Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Rapid Antigen Testing (RAT) for COVID-19 Distributors
8.3 Rapid Antigen Testing (RAT) for COVID-19 Production Mode & Process
8.4 Rapid Antigen Testing (RAT) for COVID-19 Sales and Marketing
8.4.1 Rapid Antigen Testing (RAT) for COVID-19 Sales Channels
8.4.2 Rapid Antigen Testing (RAT) for COVID-19 Distributors
8.5 Rapid Antigen Testing (RAT) for COVID-19 Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables Table 1. Rapid Antigen Testing (RAT) for COVID-19 CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Rapid Antigen Testing (RAT) for COVID-19 Market Trends Table 3. Rapid Antigen Testing (RAT) for COVID-19 Market Drivers Table 4. Rapid Antigen Testing (RAT) for COVID-19 Market Challenges Table 5. Rapid Antigen Testing (RAT) for COVID-19 Market Restraints Table 6. Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Rapid Antigen Testing (RAT) for COVID-19 Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Rapid Antigen Testing (RAT) for COVID-19 Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Rapid Antigen Testing (RAT) for COVID-19 Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Share by Manufacturer, 2017-2022 Table 13. Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Manufacturer, (K Units), 2017-2022 Table 14. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Share by Manufacturer, 2017-2022 Table 15. Global Rapid Antigen Testing (RAT) for COVID-19 Price by Manufacturer (2017-2022) & (US$/Unit) Table 16. Global Rapid Antigen Testing (RAT) for COVID-19 Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Rapid Antigen Testing (RAT) for COVID-19 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Antigen Testing (RAT) for COVID-19 as of 2021) Table 18. Top Players of Rapid Antigen Testing (RAT) for COVID-19 in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Rapid Antigen Testing (RAT) for COVID-19 Product Type Table 20. Date of International Manufacturers Enter into Rapid Antigen Testing (RAT) for COVID-19 Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Rapid Antigen Testing (RAT) for COVID-19 Players in United States Market, Ranking by Revenue (2021) Table 23. United States Rapid Antigen Testing (RAT) for COVID-19 Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Rapid Antigen Testing (RAT) for COVID-19 Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Rapid Antigen Testing (RAT) for COVID-19 Sales by Players, (K Units), 2020, 2021 & 2022 Table 26. United States Rapid Antigen Testing (RAT) for COVID-19 Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Rapid Antigen Testing (RAT) for COVID-19 Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Rapid Antigen Testing (RAT) for COVID-19 Sales in Volume by Region (2017-2022) & (K Units) Table 29. Global Rapid Antigen Testing (RAT) for COVID-19 Sales in Volume Forecast by Region (2023-2028) & (K Units) Table 30. Global Rapid Antigen Testing (RAT) for COVID-19 Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Rapid Antigen Testing (RAT) for COVID-19 Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Rapid Antigen Testing (RAT) for COVID-19 Sales in Volume by Country (2017-2028) & (K Units) Table 33. North America Rapid Antigen Testing (RAT) for COVID-19 Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Sales in Volume by Region (2017-2028) & (K Units) Table 35. Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Rapid Antigen Testing (RAT) for COVID-19 Sales in Volume by Country (2017-2028) & (K Units) Table 37. Europe Rapid Antigen Testing (RAT) for COVID-19 Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Rapid Antigen Testing (RAT) for COVID-19 Sales in Volume by Country (2017-2028) & (K Units) Table 39. Latin Americaa Rapid Antigen Testing (RAT) for COVID-19 Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Rapid Antigen Testing (RAT) for COVID-19 Sales in Volume by Country (2017-2028) & (K Units) Table 41. Middle East and Africa Rapid Antigen Testing (RAT) for COVID-19 Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Abbott Corporation Information Table 43. Abbott Description and Business Overview Table 44. Abbott Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 45. Abbott Rapid Antigen Testing (RAT) for COVID-19 Product Table 46. Abbott Recent Development Table 47. Quidel Corporation Information Table 48. Quidel Description and Business Overview Table 49. Quidel Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 50. Quidel Product Table 51. Quidel Recent Development Table 52. ACCESS BIO Corporation Information Table 53. ACCESS BIO Description and Business Overview Table 54. ACCESS BIO Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 55. ACCESS BIO Product Table 56. ACCESS BIO Recent Development Table 57. CTK Biotech Corporation Information Table 58. CTK Biotech Description and Business Overview Table 59. CTK Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 60. CTK Biotech Product Table 61. CTK Biotech Recent Development Table 62. SD Biosensor Corporation Information Table 63. SD Biosensor Description and Business Overview Table 64. SD Biosensor Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 65. SD Biosensor Product Table 66. SD Biosensor Recent Development Table 67. Ellume Corporation Information Table 68. Ellume Description and Business Overview Table 69. Ellume Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 70. Ellume Product Table 71. Ellume Recent Development Table 72. InBios Corporation Information Table 73. InBios Description and Business Overview Table 74. InBios Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 75. InBios Product Table 76. InBios Recent Development Table 77. Celltrion Corporation Information Table 78. Celltrion Description and Business Overview Table 79. Celltrion Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 80. Celltrion Product Table 81. Celltrion Recent Development Table 82. AESKU.GROUP Corporation Information Table 83. AESKU.GROUP Description and Business Overview Table 84. AESKU.GROUP Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 85. AESKU.GROUP Product Table 86. AESKU.GROUP Recent Development Table 87. ROCHE Corporation Information Table 88. ROCHE Description and Business Overview Table 89. ROCHE Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 90. ROCHE Product Table 91. ROCHE Recent Development Table 92. BD Corporation Information Table 93. BD Description and Business Overview Table 94. BD Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 95. BD Product Table 96. BD Recent Development Table 97. OraSure Technologies Corporation Information Table 98. OraSure Technologies Description and Business Overview Table 99. OraSure Technologies Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 100. OraSure Technologies Product Table 101. OraSure Technologies Recent Development Table 102. Clip Health Corporation Information Table 103. Clip Health Description and Business Overview Table 104. Clip Health Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 105. Clip Health Product Table 106. Clip Health Recent Development Table 107. LumiraDx Corporation Information Table 108. LumiraDx Description and Business Overview Table 109. LumiraDx Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 110. LumiraDx Product Table 111. LumiraDx Recent Development Table 112. Princeton BioMeditech Corporation Corporation Information Table 113. Princeton BioMeditech Corporation Description and Business Overview Table 114. Princeton BioMeditech Corporation Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 115. Princeton BioMeditech Corporation Product Table 116. Princeton BioMeditech Corporation Recent Development Table 117. RapiGEN Inc. Corporation Information Table 118. RapiGEN Inc. Description and Business Overview Table 119. RapiGEN Inc. Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 120. RapiGEN Inc. Product Table 121. RapiGEN Inc. Recent Development Table 122. Orient Gene Corporation Information Table 123. Orient Gene Description and Business Overview Table 124. Orient Gene Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 125. Orient Gene Product Table 126. Orient Gene Recent Development Table 127. Wondfo Biotech Corporation Information Table 128. Wondfo Biotech Description and Business Overview Table 129. Wondfo Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 130. Wondfo Biotech Product Table 131. Wondfo Biotech Recent Development Table 132. Ihealth (Andon Health) Corporation Information Table 133. Ihealth (Andon Health) Description and Business Overview Table 134. Ihealth (Andon Health) Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 135. Ihealth (Andon Health) Product Table 136. Ihealth (Andon Health) Recent Development Table 137. Wantai BioPharm Corporation Information Table 138. Wantai BioPharm Description and Business Overview Table 139. Wantai BioPharm Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 140. Wantai BioPharm Product Table 141. Wantai BioPharm Recent Development Table 142. Biotest Biotech Corporation Information Table 143. Biotest Biotech Description and Business Overview Table 144. Biotest Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 145. Biotest Biotech Product Table 146. Biotest Biotech Recent Development Table 147. Shenzhen YHLO Biotech Corporation Information Table 148. Shenzhen YHLO Biotech Description and Business Overview Table 149. Shenzhen YHLO Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 150. Shenzhen YHLO Biotech Product Table 151. Shenzhen YHLO Biotech Recent Development Table 152. Vazyme Biotech Corporation Information Table 153. Vazyme Biotech Description and Business Overview Table 154. Vazyme Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 155. Vazyme Biotech Product Table 156. Vazyme Biotech Recent Development Table 157. EasyDiagnosis Biomedicine Corporation Information Table 158. EasyDiagnosis Biomedicine Description and Business Overview Table 159. EasyDiagnosis Biomedicine Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 160. EasyDiagnosis Biomedicine Product Table 161. EasyDiagnosis Biomedicine Recent Development Table 162. Beijing Hotgen Biotech Corporation Information Table 163. Beijing Hotgen Biotech Description and Business Overview Table 164. Beijing Hotgen Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 165. Beijing Hotgen Biotech Product Table 166. Beijing Hotgen Biotech Recent Development Table 167. Assure Tech Corporation Information Table 168. Assure Tech Description and Business Overview Table 169. Assure Tech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 170. Assure Tech Product Table 171. Assure Tech Recent Development Table 172. Hangzhou AllTest Biotech Corporation Information Table 173. Hangzhou AllTest Biotech Description and Business Overview Table 174. Hangzhou AllTest Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 175. Hangzhou AllTest Biotech Product Table 176. Hangzhou AllTest Biotech Recent Development Table 177. ACON Biotech Corporation Information Table 178. ACON Biotech Description and Business Overview Table 179. ACON Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 180. ACON Biotech Product Table 181. ACON Biotech Recent Development Table 182. BGI Genomics Corporation Information Table 183. BGI Genomics Description and Business Overview Table 184. BGI Genomics Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 185. BGI Genomics Product Table 186. BGI Genomics Recent Development Table 187. Lepu Medical Technology Corporation Information Table 188. Lepu Medical Technology Description and Business Overview Table 189. Lepu Medical Technology Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 190. Lepu Medical Technology Product Table 191. Lepu Medical Technology Recent Development Table 192. Key Raw Materials Lists Table 193. Raw Materials Key Suppliers Lists Table 194. Rapid Antigen Testing (RAT) for COVID-19 Customers List Table 195. Rapid Antigen Testing (RAT) for COVID-19 Distributors List Table 196. Research Programs/Design for This Report Table 197. Key Data Information from Secondary Sources Table 198. Key Data Information from Primary Sources List of Figures Figure 1. Rapid Antigen Testing (RAT) for COVID-19 Product Picture Figure 2. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Rapid Antigen Testing (RAT) for COVID-19 Market Size 2017-2028 (US$ Million) Figure 4. Global Rapid Antigen Testing (RAT) for COVID-19 Sales 2017-2028 (K Units) Figure 5. United States Rapid Antigen Testing (RAT) for COVID-19 Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Rapid Antigen Testing (RAT) for COVID-19 Market Size 2017-2028 (US$ Million) Figure 7. United States Rapid Antigen Testing (RAT) for COVID-19 Sales 2017-2028 (K Units) Figure 8. United States Rapid Antigen Testing (RAT) for COVID-19 Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Rapid Antigen Testing (RAT) for COVID-19 Market Share in Global, in Volume (K Units) 2017-2028 Figure 10. Rapid Antigen Testing (RAT) for COVID-19 Report Years Considered Figure 11. Product Picture of Fluorescence Immunochromatography Figure 12. Product Picture of Colloidal Gold Immunochromatography Figure 13. Product Picture of Latex Immunochromatography Figure 14. Product Picture of Others Figure 15. Global Rapid Antigen Testing (RAT) for COVID-19 Market Share by Type in 2022 & 2028 Figure 16. Global Rapid Antigen Testing (RAT) for COVID-19 Sales in Value by Type (2017-2028) & (US$ Million) Figure 17. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share in Value by Type (2017-2028) Figure 18. Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Type (2017-2028) & (K Units) Figure 19. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share in Volume by Type (2017-2028) Figure 20. Global Rapid Antigen Testing (RAT) for COVID-19 Price by Type (2017-2028) & (US$/Unit) Figure 21. United States Rapid Antigen Testing (RAT) for COVID-19 Market Share by Type in 2022 & 2028 Figure 22. United States Rapid Antigen Testing (RAT) for COVID-19 Sales in Value by Type (2017-2028) & (US$ Million) Figure 23. United States Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share in Value by Type (2017-2028) Figure 24. United States Rapid Antigen Testing (RAT) for COVID-19 Sales by Type (2017-2028) & (K Units) Figure 25. United States Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share in Volume by Type (2017-2028) Figure 26. United States Rapid Antigen Testing (RAT) for COVID-19 Price by Type (2017-2028) & (US$/Unit) Figure 27. Product Picture of Hospitals Figure 28. Product Picture of Community Testing Figure 29. Product Picture of Other Figure 30. Global Rapid Antigen Testing (RAT) for COVID-19 Market Share by Application in 2022 & 2028 Figure 31. Global Rapid Antigen Testing (RAT) for COVID-19 Sales in Value by Application (2017-2028) & (US$ Million) Figure 32. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share in Value by Application (2017-2028) Figure 33. Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Application (2017-2028) & (K Units) Figure 34. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share in Volume by Application (2017-2028) Figure 35. Global Rapid Antigen Testing (RAT) for COVID-19 Price by Application (2017-2028) & (US$/Unit) Figure 36. United States Rapid Antigen Testing (RAT) for COVID-19 Market Share by Application in 2022 & 2028 Figure 37. United States Rapid Antigen Testing (RAT) for COVID-19 Sales in Value by Application (2017-2028) & (US$ Million) Figure 38. United States Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share in Value by Application (2017-2028) Figure 39. United States Rapid Antigen Testing (RAT) for COVID-19 Sales by Application (2017-2028) & (K Units) Figure 40. United States Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share in Volume by Application (2017-2028) Figure 41. United States Rapid Antigen Testing (RAT) for COVID-19 Price by Application (2017-2028) & (US$/Unit) Figure 42. North America Rapid Antigen Testing (RAT) for COVID-19 Sales in Volume Growth Rate 2017-2028 (K Units) Figure 43. North America Rapid Antigen Testing (RAT) for COVID-19 Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 44. United States Rapid Antigen Testing (RAT) for COVID-19 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 45. Canada Rapid Antigen Testing (RAT) for COVID-19 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 46. Europe Rapid Antigen Testing (RAT) for COVID-19 Sales in Volume Growth Rate 2017-2028 (K Units) Figure 47. Europe Rapid Antigen Testing (RAT) for COVID-19 Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 48. Germany Rapid Antigen Testing (RAT) for COVID-19 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. France Rapid Antigen Testing (RAT) for COVID-19 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. U.K. Rapid Antigen Testing (RAT) for COVID-19 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. Italy Rapid Antigen Testing (RAT) for COVID-19 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 52. Russia Rapid Antigen Testing (RAT) for COVID-19 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 53. Asia-Pacific Rapid Antigen Testing (RAT) for COVID-19 Sales in Volume Growth Rate 2017-2028 (K Units) Figure 54. Asia-Pacific Rapid Antigen Testing (RAT) for COVID-19 Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 55. China Rapid Antigen Testing (RAT) for COVID-19 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. Japan Rapid Antigen Testing (RAT) for COVID-19 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. South Korea Rapid Antigen Testing (RAT) for COVID-19 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. India Rapid Antigen Testing (RAT) for COVID-19 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Australia Rapid Antigen Testing (RAT) for COVID-19 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. China Taiwan Rapid Antigen Testing (RAT) for COVID-19 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Indonesia Rapid Antigen Testing (RAT) for COVID-19 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Thailand Rapid Antigen Testing (RAT) for COVID-19 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Malaysia Rapid Antigen Testing (RAT) for COVID-19 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 64. Latin America Rapid Antigen Testing (RAT) for COVID-19 Sales in Volume Growth Rate 2017-2028 (K Units) Figure 65. Latin America Rapid Antigen Testing (RAT) for COVID-19 Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 66. Mexico Rapid Antigen Testing (RAT) for COVID-19 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 67. Brazil Rapid Antigen Testing (RAT) for COVID-19 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 68. Argentina Rapid Antigen Testing (RAT) for COVID-19 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 69. Colombia Rapid Antigen Testing (RAT) for COVID-19 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 70. Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Sales in Volume Growth Rate 2017-2028 (K Units) Figure 71. Middle East & Africa Rapid Antigen Testing (RAT) for COVID-19 Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 72. Turkey Rapid Antigen Testing (RAT) for COVID-19 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 73. Saudi Arabia Rapid Antigen Testing (RAT) for COVID-19 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 74. UAE Rapid Antigen Testing (RAT) for COVID-19 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 75. Rapid Antigen Testing (RAT) for COVID-19 Value Chain Figure 76. Rapid Antigen Testing (RAT) for COVID-19 Production Process Figure 77. Channels of Distribution Figure 78. Distributors Profiles Figure 79. Bottom-up and Top-down Approaches for This Report Figure 80. Data Triangulation Figure 81. Key Executives Interviewed
Market Analysis and Insights: Global and United States Rapid Antigen Testing (RAT) for COVID-19 Market This report focuses on global and United States Rapid Antigen Testing (RAT) for COVID-19 market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Rapid Antigen Testing (RAT) for COVID-19 market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Fluorescence Immunochromatography accounting for % of the Rapid Antigen Testing (RAT) for COVID-19 global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospitals was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period. In United States the Rapid Antigen Testing (RAT) for COVID-19 market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028. Global Rapid Antigen Testing (RAT) for COVID-19 Scope and Market Size Rapid Antigen Testing (RAT) for COVID-19 market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Rapid Antigen Testing (RAT) for COVID-19 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Rapid Antigen Testing (RAT) for COVID-19 market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States. Segment by Type Fluorescence Immunochromatography Colloidal Gold Immunochromatography Latex Immunochromatography Others Segment by Application Hospitals Community Testing Other By Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Colombia Middle East & Africa Turkey Saudi Arabia UAE By Company Abbott Quidel ACCESS BIO CTK Biotech SD Biosensor Ellume InBios Celltrion AESKU.GROUP ROCHE BD OraSure Technologies Clip Health LumiraDx Princeton BioMeditech Corporation RapiGEN Inc. Orient Gene Wondfo Biotech Ihealth (Andon Health) Wantai BioPharm Biotest Biotech Shenzhen YHLO Biotech Vazyme Biotech EasyDiagnosis Biomedicine Beijing Hotgen Biotech Assure Tech Hangzhou AllTest Biotech ACON Biotech BGI Genomics Lepu Medical Technology
USD 4350.00
USD 6525.00
USD 8700.00
Add to Cart
Buy Now
A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.
In-depth research on key industry players and analysis of production and sales operations.
Objective forecasts of future trends in the industry.
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.
In-depth research on key industry players and analysis of production and sales operations.
Objective forecasts of future trends in the industry.
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
Add to Cart
Buy Now